Yes. Prostaglandin analogue eye drops, the most commonly prescribed glaucoma drops, can darken the skin around the eye, deepen the eyelid fold, lengthen lashes, and in some patients darken the iris. These changes are real, recognised, and should have been explained before your prescription was written. They are not dangerous. They do not mean you should stop the drop.
Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.
What Is a Prostaglandin Analogue?
Prostaglandin analogues are the first-line treatment for most patients with glaucoma. They work by improving drainage of fluid from the eye, lowering pressure, and protecting the optic nerve. They are effective, well-tolerated, and taken once daily, usually at night.
Common examples include latanoprost, bimatoprost, travoprost, and tafluprost. If your glaucoma drop ends in -prost, it is almost certainly in this class.
What Changes Around the Eye and Why
Prostaglandin analogues stimulate melanin-producing cells around the eye. Over months of use, this produces several visible changes.
The skin of the eyelids and the area around the eye socket darkens gradually. This is called periorbital pigmentation. It happens slowly enough that many patients do not notice it themselves until someone else points it out, or until they see a photograph.
The eyelashes grow longer, thicker, and darker. Some patients welcome this. Others find it uneven or unexpected.
In some patients, particularly those with lighter or mixed-colour irises, the iris itself can darken permanently. In brown-eyed patients, this change is usually not visible.
There is also a structural change called prostaglandin-associated periorbitopathy. The fatty tissue around the eye socket thins. The upper eyelid develops a deeper fold. The eye may appear more sunken. This is subtle in most patients but noticeable in some, particularly after years of use.
Why Were You Not Told
Glaucoma consultations carry a great deal of information. Pressure numbers. Nerve scans. Field tests. Drop instructions. Cosmetic side effects that carry no medical risk sometimes do not make it into the conversation.
Patients who notice an unexpected change in their appearance and do not know why it is happening sometimes stop their drops. Stopping glaucoma drops without guidance can cause serious, irreversible vision loss.
You are entitled to know everything a treatment may do. Not just the part that fixes the problem. So please discuss with your doctor, and she will talk to you about managing the side effects.
Should You Stop the Drop
No. Not without speaking to your glaucoma specialist first.
Uncontrolled glaucoma causes permanent optic nerve damage. These cosmetic changes do not. The risk comparison is not close.
What you should do is tell your doctor. There are other classes of glaucoma drops that do not carry this effect. Beta blockers, alpha agonists, and carbonic anhydrase inhibitors work differently and do not cause periorbital pigmentation. In some patients, switching is appropriate. In others, the prostaglandin is the best option for controlling pressure and the cosmetic effect is manageable.
That conversation should happen with your specialist, with your actual pressure readings and nerve scans on the table. Not as a self-managed decision.
What to Do If You Have Already Noticed This
Bring it up at your next appointment. If it is significantly affecting you, request an earlier one. Ask specifically whether an alternative drop or laser would control your pressure equally well.
If you are newly diagnosed and being started on a prostaglandin drop, ask your doctor to walk you through what changes to expect and over what timeframe. This is not an unreasonable question. It is your face, and your treatment.
FAQs:
Will the Skin Darkening Go Away If I Stop the Drop?
Periorbital skin pigmentation partially reverses after stopping the drop, but this takes months and may not fully resolve. The structural changes of periorbitopathy are slower to reverse. Iris darkening, if it has occurred, is permanent. This is another reason why the conversation about side effects should happen before starting treatment, not after changes have already appeared.
Does This Happen to Everyone on Prostaglandin Drops?
No. The degree of change varies considerably between patients. Some patients use prostaglandin drops for years with minimal visible effect. Others notice changes within a few months. Patients with lighter skin tones may notice periorbital pigmentation more readily. Those with mixed-colour irises are more likely to develop iris darkening. Your specialist can discuss your individual risk based on your eye colour, skin tone, and the specific drop prescribed.
Can I Use the Drop in Only One Eye to Avoid Asymmetric Changes?
If your glaucoma affects only one eye, your doctor may prescribe the drop for that eye only. In this case, asymmetric cosmetic changes are possible — the treated eye may develop darker periorbital skin or longer lashes than the untreated side. This is worth discussing with your specialist before starting, so you can make an informed decision about treatment options.
Are There Glaucoma Drops That Do Not Cause This?
Yes. Beta blockers such as timolol, alpha agonists such as brimonidine, and carbonic anhydrase inhibitors such as dorzolamide do not cause periorbital pigmentation or periorbitopathy. Combination drops that include these classes are also available. Whether they are suitable for you depends on your pressure control needs, your general health, and other medications you may be taking. Your glaucoma specialist can advise.
Is This a Sign That the Drop Is Harming My Eye?
No. These are surface and structural changes around the eye, not damage to the optic nerve or retina. The drop is doing its job inside the eye. The cosmetic effects are a separate matter. Stopping the drop because of skin darkening, without medical guidance, risks the thing that actually matters: your vision.
About the Author
This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.
She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.
As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.
1500+ Five Star Patient Reviews Google Business Profile
If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma
Read her research on PubMed | Google Scholar | ResearchGate | ORCID
Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735
Leave a review on Google